
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (OTCID:NYMXF) through any online brokerage.
There are no as such competitors for NYMOX PHARM CORP by Nymox Pharmaceutical Corp..
There is no analysis for NYMOX PHARM CORP by Nymox Pharmaceutical Corp. to provide a consensus price target.
The stock price for NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (OTCID: NYMXF) is $0.032 last updated October 20, 2026 at 12:08 PM EDT.
There are no upcoming dividends for NYMOX PHARM CORP by Nymox Pharmaceutical Corp..
NYMOX PHARM CORP by Nymox Pharmaceutical Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for NYMOX PHARM CORP by Nymox Pharmaceutical Corp..
NYMOX PHARM CORP by Nymox Pharmaceutical Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCID.
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing NYMOZARFEX (fexapotide/NX-1207) for the treatment of benign prostatic hyperplasia (BPH) and low-grade localized prostate cancer. The company also has...